A One Pot Synthesis of Novel Bioactive Tri-Substitute-Condensed-Imidazopyridines that Targets Snake Venom Phospholipase A2.

by Nirvanappa C Anilkumar, Mahalingam S Sundaram, Chakrabhavi Dhananjaya Mohan, Shobith Rangappa, Krishna C Bulusu, Julian E Fuchs, Kesturu S Girish, Andreas Bender, Basappa, Kanchugarakoppal S Rangappa
Published 2015-01-01

Neighbours of cancer-related proteins have key influence on pathogenesis and could increase the drug target space for anticancer therapies

by Dezső Módos, Krishna C. Bulusu, Dávid Fazekas, János Kubisch, Johanne Brooks, István Marczell, Péter M. Szabó, Tibor Vellai, Péter Csermely, Katalin Lenti, Andreas Bender, Tamás Korcsmáros
Published 2017-01-01

Novel Adamantanyl-Based Thiadiazolyl Pyrazoles Targeting EGFR in Triple-Negative Breast Cancer

by Anusha Sebastian, Vijay Pandey, Chakrabhavi Dhananjaya Mohan, Yi Ting Chia, Shobith Rangappa, Jessin Mathai, C. P. Baburajeev, Shardul Paricharak, Lewis H. Mervin, Krishna C. Bulusu, Julian E. Fuchs, Andreas Bender, Shuhei Yamada, Basappa, Peter E. Lobie, Kanchugarakoppal S. Rangappa
Published 2016-12-01

Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen

by Michael P. Menden, Dennis Wang, Mike J. Mason, Bence Szalai, Krishna C. Bulusu, Yuanfang Guan, Thomas Yu, Jaewoo Kang, Minji Jeon, Russ Wolfinger, Tin Nguyen, Mikhail Zaslavskiy, AstraZeneca-Sanger Drug Combination DREAM Consortium, In Sock Jang, Zara Ghazoui, Mehmet Eren Ahsen, Robert Vogel, Elias Chaibub Neto, Thea Norman, Eric K. Y. Tang, Mathew J. Garnett, Giovanni Y. Di Veroli, Stephen Fawell, Gustavo Stolovitzky, Justin Guinney, Jonathan R. Dry, Julio Saez-Rodriguez
Published 2019-06-01